Aug 23, 2021 An overview of recent FDA activity on materials in medical devices By Mary Gately Christopher Campbell In this article, the authors provide an overview of recent US Food and Drug Administration (FDA) interest and activity relating to the...
Aug 20, 2021 Patent eligibility of diagnostic methods in Australia confirmed: Ariosa Diagnostics, Inc v Sequenom, Inc [2021] FCAFC 101 By Nicholas Tyacke Alexandra de Zwart Sab Singh For many years, the following question awaited judicial determination under Australian law: is a DNA-based diagnostic method patent...
Aug 20, 2021 Patent term extensions in Australia - A significant victory for pharmaceutical patentees By Nicholas Tyacke Summary In a significant victory for pharmaceutical patentees, the Federal Court in Ono Pharmaceutical Co. Ltd v Commissioner of Patents...
Aug 11, 2021 Medical Cannabis: Proposed Changes and Legal Implications in the Czech Republic By Jan Metelka Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise...
Aug 05, 2021 Australian Court determines that an Artificial Intelligence system can be an inventor for the purposes of patent law By Nicholas Tyacke Alexandra de Zwart Artificial Intelligence (AI) and machine learning are increasingly used in the life sciences industry for research and drug discovery,...